Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
This eliminates the need for manual math and reduces errors
Hepatology 58 , 13851391 (2013)
Professional Use
Overall Adverse Event Rates Dose Group Any Adverse Event (%) GI Adverse Events (%) Discontinuation Due to AE (%) Placebo 72.1% 32.6% 0% 1 mg 88.6% 48.6% 2.9% 4 mg (escalated) 88.6% 60.0% 5.7% 4 mg (single dose) 90.9% 63.6% 6.1% 8 mg (escalated) 87.5% 57.5% 5.0% 8 mg (single dose) 88.6% 62.9% 5.7% 12 mg (escalated) 97.2% 66.7% 8.3% Source: Jastreboff AM, Kaplan LM, Fras JP, et al
placebo for 12 weeks, and this was associated with reduced appetite and food cravings, better control of eating, and lower preference for fatty, energy-dense food (77)
We prescribe FDA-approved brand medication as the default and only discuss compounded options when there is a documented clinical reason
US$ 23.24
US$ 27.96
US$ 23.82
US$ 24.50
US$ 23.70
US$ 23.17
